Condition
Demodex Infestation
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05454956Phase 2Completed
Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD
NCT06185699Not ApplicableCompleted
Could Wearing Face Mask Have Affected Demodex Parasite
NCT04377841UnknownPrimary
Facial Demodicosis and Ocular Demodicosis
NCT04204954Phase 2CompletedPrimary
Evaluation of Treatment Option for Demodicosis in Patients Undergoing Cataract Surgery
Showing all 4 trials